Related Experiment Videos

Protein profiling: a possible molecular mechanism to mislocalization and down-expression of p27(Kip1) in tumor cells

Xiaoxiang Guan1, Longbang Chen, Jinghua Wang

  • 1Department of Oncology, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China. nj_guan@yahoo.com

Medical Hypotheses
|March 16, 2007
PubMed

Insights

The cell cycle inhibitor p27 (also known as p27Kip1) is crucial for cell processes. Abnormal p27 expression or location in tumors may be linked to different protein interactions, impacting cancer progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • p27(Kip1) (p27) is a cyclin-dependent kinase inhibitor regulating cell cycle, proliferation, differentiation, and apoptosis.
  • p27 functions as a prognostic factor in various cancers and is a therapeutic target.
  • Tumor cells often exhibit down-regulated p27 expression or cytoplasmic mislocalization, correlating with adverse prognosis.

Purpose of the Study:

  • To investigate the molecular mechanisms behind abnormal p27 expression and mislocalization in tumor cells.
  • To explore the role of p27 interacting proteins in its dysregulation within cancer.

Main Methods:

  • The study focuses on analyzing the protein interaction profiles associated with p27.
  • Investigating how different p27 complex formations contribute to aberrant expression and localization.

Main Results:

  • Abnormal expression and cytoplasmic localization of p27 in tumor cells are observed.
  • Preliminary evidence suggests that altered p27 protein interactions may underlie these dysregulations.

Conclusions:

  • Altered protein interaction profiles are hypothesized to be a fundamental mechanism driving abnormal p27 expression and cytoplasmic localization in cancer cells.
  • Understanding these interactions could reveal new therapeutic strategies targeting p27 in cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...